New Phase, a leading oncology company pioneering the emerging field of Electromagnetic Hyperthermia, is proud to close 2025 with a major milestone of initiation its clinical study at Mayo Clinic, one of the world’s leading and most respected medical institutions.

This collaboration brings togethe Mayo Clinic’s highly experienced oncology team and New Phase’s groundbreaking technology, with a shared mission to advance innovative treatment options for patients with metastatic cancer.Together, the teams are working to translate scientific innovation into meaningful clinical impact, opening a new chapter in the fight against advanced-stage cancer.